FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166315341> ?p ?o ?g. }

• W3166315341 endingPage "5815" @default.
• W3166315341 startingPage "5805" @default.
• W3166315341 abstract "Aggressive immune response, due to overexpressed proinflammatory molecules, has been characterized in coronavirus disease 2019 (COVID-19) patients. Some of those mediators have a dual and opposite role on immune systems at play behind differential disease severities. We investigated the expression of some cytokines and chemokines in COVID-19 patients in Bangladesh. We diagnosed the patients by detecting severe acute respiratory syndrome coronavirus 2 RNA in nasal swab samples by the real-time RT-PCR method. Thirty adult patients were preselected based on their disease severities and grouped into mild, moderate, and severe cases. Nine healthy volunteers participated in this study as a control. Relative expression of nine cytokines/chemokine in total leukocytes was semi-quantified in SYBRgreen-based real-time quantitative reverse-transcriptase polymerase chain reaction. We performed statistical tests on transformed log data using SPSS 24.0. At the onset of symptoms (Day 1), angiotensin-converting enzyme 2 (ACE2) (p < 0.05) and interleukin (IL)-6 (p > 0.05) were upregulated in all COVID-19 groups, although the expression levels did not significantly correlate with disease severities. However, expressions of IL-6, monocyte chemotactic protein-1, macrophage inflammatory protein-1α, tumor necrosis factor-α (TNF-α), RANTES (regulated upon activation, normal T cell expressed and secreted), and ACE2, on Day 14, were positively correlated with disease severities. Relative viral load at Day 1 showed no significant correlation with cytokine expression but had a significant positive correlation with RANTES and ACE2 expression on Day 14 (p < 0.05). Male patients had a higher level of IL-6 than female patients on Day 1 (p < 0.05). All COVID-19 patients showed upregulated cytokines and chemokines on Day 14 compared to Day 1 except TNF-α. Female patients had a higher expression of ACE2 and IL-12 on Day 14. Upregulated cytokines/chemokines at the convalescent stage, especially IL-6, may help in targeting anticytokine therapy in post-COVID-19 patients' management." @default.
• W3166315341 created "2021-06-22" @default.
• W3166315341 creator A5000783710 @default.
• W3166315341 creator A5005996268 @default.
• W3166315341 creator A5015220813 @default.
• W3166315341 creator A5018363028 @default.
• W3166315341 creator A5025742099 @default.
• W3166315341 creator A5027619821 @default.
• W3166315341 creator A5042361226 @default.
• W3166315341 creator A5082190306 @default.
• W3166315341 creator A5082781072 @default.
• W3166315341 date "2021-06-12" @default.
• W3166315341 modified "2023-10-03" @default.
• W3166315341 title "Relative expression of proinflammatory molecules in COVID‐19 patients who manifested disease severities" @default.
• W3166315341 cites W1859742880 @default.
• W3166315341 cites W1966238900 @default.
• W3166315341 cites W2005951646 @default.
• W3166315341 cites W2064595204 @default.
• W3166315341 cites W2070463916 @default.
• W3166315341 cites W2107277218 @default.
• W3166315341 cites W2192080449 @default.
• W3166315341 cites W2224952942 @default.
• W3166315341 cites W2471732223 @default.
• W3166315341 cites W2911782966 @default.
• W3166315341 cites W3001118548 @default.
• W3166315341 cites W3002108456 @default.
• W3166315341 cites W3004824173 @default.
• W3166315341 cites W3008090866 @default.
• W3166315341 cites W3008443627 @default.
• W3166315341 cites W3008649550 @default.
• W3166315341 cites W3009859788 @default.
• W3166315341 cites W3012421327 @default.
• W3166315341 cites W3015549965 @default.
• W3166315341 cites W3015601268 @default.
• W3166315341 cites W3016489853 @default.
• W3166315341 cites W3019785070 @default.
• W3166315341 cites W3020893626 @default.
• W3166315341 cites W3021720313 @default.
• W3166315341 cites W3022321990 @default.
• W3166315341 cites W3026456801 @default.
• W3166315341 cites W3030568918 @default.
• W3166315341 cites W3030871984 @default.
• W3166315341 cites W3032543466 @default.
• W3166315341 cites W3036563213 @default.
• W3166315341 cites W3039477378 @default.
• W3166315341 cites W3041146203 @default.
• W3166315341 cites W3041837203 @default.
• W3166315341 cites W3041881467 @default.
• W3166315341 cites W3042607231 @default.
• W3166315341 cites W3081129621 @default.
• W3166315341 cites W3091873439 @default.
• W3166315341 cites W3092079486 @default.
• W3166315341 cites W3093211696 @default.
• W3166315341 cites W3094585742 @default.
• W3166315341 cites W3108081876 @default.
• W3166315341 cites W3110924399 @default.
• W3166315341 cites W3112849794 @default.
• W3166315341 cites W3121109439 @default.
• W3166315341 cites W3166315341 @default.
• W3166315341 doi "https://doi.org/10.1002/jmv.27112" @default.
• W3166315341 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8242694" @default.
• W3166315341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34061395" @default.
• W3166315341 hasPublicationYear "2021" @default.
• W3166315341 type Work @default.
• W3166315341 sameAs 3166315341 @default.
• W3166315341 citedByCount "4" @default.
• W3166315341 countsByYear W31663153412021 @default.
• W3166315341 countsByYear W31663153412022 @default.
• W3166315341 countsByYear W31663153412023 @default.
• W3166315341 crossrefType "journal-article" @default.
• W3166315341 hasAuthorship W3166315341A5000783710 @default.
• W3166315341 hasAuthorship W3166315341A5005996268 @default.
• W3166315341 hasAuthorship W3166315341A5015220813 @default.
• W3166315341 hasAuthorship W3166315341A5018363028 @default.
• W3166315341 hasAuthorship W3166315341A5025742099 @default.
• W3166315341 hasAuthorship W3166315341A5027619821 @default.
• W3166315341 hasAuthorship W3166315341A5042361226 @default.
• W3166315341 hasAuthorship W3166315341A5082190306 @default.
• W3166315341 hasAuthorship W3166315341A5082781072 @default.
• W3166315341 hasBestOaLocation W31663153411 @default.
• W3166315341 hasConcept C101666144 @default.
• W3166315341 hasConcept C104317684 @default.
• W3166315341 hasConcept C126322002 @default.
• W3166315341 hasConcept C13373296 @default.
• W3166315341 hasConcept C164027704 @default.
• W3166315341 hasConcept C170217031 @default.
• W3166315341 hasConcept C17991360 @default.
• W3166315341 hasConcept C203014093 @default.
• W3166315341 hasConcept C2776914184 @default.
• W3166315341 hasConcept C2778690821 @default.
• W3166315341 hasConcept C2779134260 @default.
• W3166315341 hasConcept C2781184567 @default.
• W3166315341 hasConcept C48023723 @default.
• W3166315341 hasConcept C55493867 @default.
• W3166315341 hasConcept C71924100 @default.
• W3166315341 hasConcept C86803240 @default.
• W3166315341 hasConcept C8891405 @default.
• W3166315341 hasConceptScore W3166315341C101666144 @default.

• next